SCHEMBL6517422

SCHEMBL6517422

NC(CCC1CCCC1)CC(=O)O

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 1/20 0.49
ALDH1A1 P00352 1/20 0.42
SLC1A3 P43003 4/20 0.39
SLC1A2 P43004 4/20 0.39
SLC1A1 P43005 4/20 0.39
GRIK1 P39086 2/20 0.38
GRIK2 Q13002 1/20 0.38
ALOX5 P09917 2/20 0.37
METAP2 P50579 1/20 0.37
ANPEP P15144 2/20 0.36
ENPEP Q07075 1/20 0.36
DPP4 P27487 1/20 0.36
KDM5A P29375 1/20 0.35
KDM4C Q9H3R0 1/20 0.35
PHF8 Q9UPP1 1/20 0.35
KDM2A Q9Y2K7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18939426 0.98 METAP1 (0.51) METAP1ALDH1A1SLC1A3SLC1A2SLC1A1
SCHEMBL1162229 0.98 METAP1 (0.51) METAP1ALDH1A1SLC1A3SLC1A2SLC1A1
SCHEMBL3996259 0.87 METAP1 (0.41) METAP1ALDH1A1SLC1A3SLC1A2SLC1A1
SCHEMBL4001294 0.87 METAP1 (0.41) METAP1ALDH1A1SLC1A3SLC1A2SLC1A1
SCHEMBL4000605 0.87 METAP1 (0.41) METAP1ALDH1A1SLC1A3SLC1A2SLC1A1
SCHEMBL1814190 0.85 METAP1 (0.44) METAP1ALDH1A1SLC1A3SLC1A2SLC1A1
SCHEMBL1817699 0.85 METAP1 (0.44) METAP1ALDH1A1SLC1A3SLC1A2SLC1A1
SCHEMBL3994705 0.85 METAP1 (0.44) METAP1ALDH1A1SLC1A3SLC1A2SLC1A1
SCHEMBL3967280 0.83 METAP1 (0.41) METAP1ALDH1A1SLC1A3SLC1A2SLC1A1
SCHEMBL3958014 0.83 METAP1 (0.41) METAP1ALDH1A1SLC1A3SLC1A2SLC1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050009151-A1 Methods for the stereospecific and enantiomeric enrichment of beta-amino acids PHARMACIA CORPORATION 2005-01-13 US disclosed